Atlas Trials

Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic Conjunctivitis

Clinical trial NCT05591755 · COMPLETED

Trial details

NCT number
NCT05591755
Sponsor
Bausch & Lomb Incorporated
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Seasonal Allergic Conjunctivitis
Start date
2022-11-18
Primary completion
2023-08-09
Enrollment
229

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.